TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

Isabel Puig(Institut Curie), Héctor G. Pálmer(Vall d'Hebron Institute of Oncology)
Journal of Clinical Investigation
June 26, 2018
Cited by 107


Related Papers